Education
About Us
Working with TipRanks
Follow Us
Evolva Holding (CH:EVE)
:EVE
EVE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeCHF0.75 - CHF1.69
Previous CloseN/A
Volume16.51K
Average Volume (3M)8.40K
Market Cap
$6.61M
Enterprise ValueCHF1.51M
Total Cash (Recent Filing)$6.75M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)7.6
Beta0.32
Next Earnings
Feb 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding7,230,626
10 Day Avg. Volume14,803
30 Day Avg. Volume8,404
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)0.98
Price to Sales (P/S)0.00
P/FCF Ratio-2.66
Enterprise Value/Market Cap0.23
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.30
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Evolva Holding News
EVE FAQ
What was Evolva Holding’s price range in the past 12 months?
Evolva Holding lowest stock price was CHF0.75 and its highest was CHF1.69 in the past 12 months.
What is Evolva Holding’s market cap?
Evolva Holding’s market cap is $6.61M.
When is Evolva Holding’s upcoming earnings report date?
Evolva Holding’s upcoming earnings report date is Feb 20, 2026 which is in 135 days.
How were Evolva Holding’s earnings last quarter?
Evolva Holding released its earnings results on Aug 21, 2025. The company reported -CHF0.05 earnings per share for the quarter, missing the consensus estimate of N/A by -CHF0.05.
Is Evolva Holding overvalued?
According to Wall Street analysts Evolva Holding’s price is currently Overvalued.
Does Evolva Holding pay dividends?
Evolva Holding does not currently pay dividends.
What is Evolva Holding’s EPS estimate?
Evolva Holding’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Evolva Holding have?
Evolva Holding has 7,230,626 shares outstanding.
What happened to Evolva Holding’s price movement after its last earnings report?
Evolva Holding reported an EPS of -CHF0.05 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.455%.
Which hedge fund is a major shareholder of Evolva Holding?
Currently, no hedge funds are holding shares in CH:EVE
Company Description
Evolva Holding
EvoNext Holdings SA engages in the business of researching, developing, and commercializing novel nutritional, healthcare, and wellness ingredients. The company was founded by Alexandra Santana Sørensen, Søren V. S. Nielsen, and Neil Goldsmith in 2004 and is headquartered in Reinach, Switzerland.
Technical Analysis
Molecular Partners AG
―
Newron Pharmaceuticals SpA
―
Santhera Pharmaceuticals Holding
―
RELIEF THERAPEUTICS Holding
―
Xlife Sciences Ltd.
―
Options Prices
Currently, No data available
---